|Vital Therapies, Inc.|
Vital Therapies, Inc., a biotherapeutic company, focuses on developing a cell-based therapy for the treatment of acute liver failure in the United States. Its ELAD system is an extracorporeal human allogeneic cellular liver that is in Phase III clinical trials to allow the patients own liver to regenerate to a healthy state, or to stabilize the patient until transplant. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is headquartered in San Diego, California.